Key result
High-dose inhaled corticosteroids did not affect lumbar spine bone density compared to low-dose or no use over a 3-year period.
Why the study?
Does high-dose inhaled corticosteroids reduce bone density compared to low-dose or no use in patients treated for more than 5 years?
Cohort (n=51)
Does high-dose inhaled corticosteroids reduce bone density compared to low-dose or no use in patients treated for more than 5 years?
Answers are grounded in this paper and cite their sources.
Long-term use of high-dose inhaled corticosteroids does not significantly reduce lumbar spine bone density compared to low-dose or no use over a 3-year period.
Long-term effects of high doses of inhaled corticosteroids (ICS) on bone density and metabolism are still uncertain. Fifty-one patients (37 male, 14 female) using beclomethasone or budesonide at a daily dose > 800 microgram/d (high-dose group [Group HD] mean: 983 microgram/d [prescribed dose x estimated compliance]) or no or < 500 microgram/d (control group [Group C] mean: 309 microgram/d) for more than 5 yr were enrolled in this study. Each had, 3 yr ago and at this last evaluation, a clinical evaluation and measurements of expiratory flows and of bone density and bone metabolism markers. Lumbar spine bone density (last visit) was similar in the two groups with respective values of 0.94 +/- 0.03 (HD) and 0.96 +/- 0.03 g/cm2 (C) (p > 0.05). T and Z scores were -1.21 +/- 0.19 and -0.70 +/- 0.18 (HD), -0.95 +/- 0.25 and -0.47 +/- 0.21 (C) respectively (p > 0.05). A correlation was found between the decrease in bone density and the mean daily dose of corticosteroid in Group HD although these changes were quite small, mean bone density being unchanged over the 3-yr period. Serum and urinary parameters were similar in the two groups. Furthermore, neither initial bone density nor any of the biological parameters could predict changes in bone density over a period of 3 yr. In conclusion, bone density was similar in both study groups and not significantly different over a 3-yr period. Neither initial bone density nor biological markers of bone metabolism helped to predict changes in bone mass.
No takes yet. Share an insight, caveat, or question.
Boulet et al. (1999) conducted a cohort in Patients using inhaled corticosteroids (n=51). High-dose inhaled corticosteroids vs. No or < 500 microgram/d inhaled corticosteroids was evaluated on Lumbar spine bone density (p=> 0.05). High-dose inhaled corticosteroids did not affect lumbar spine bone density compared to low-dose or no use over a 3-year period.
Synapse has enriched 10 related papers. Consider them for comparative context: